Pumpinheart wins Innovation Award at AIMS 2023
24 August 2023: Dr Aamir Hameed presented Pumpinheart’s plans to develop the PReduction Device to treat Heart Failure with preserved Ejection Fraction (HFpEF) at the American Irish Medical Summit (AIMS) 2023 at the Royal College of Surgeons in Ireland (RCSI) and won the Blackrock Health sponsored Innovation Award. The American Irish Medical Summit (AIMS) is a collaboration between physicians, leaders and innovators from America and Ireland with a shared interest and passion for cardiovascular health, medtech and academic development.
Recent News posts
![]()
HSE Spark Innovation Programme and HSE Spark Summit Innovation Conference
Congratulations to Dr. Claire Stenson, surgical SHO and RCSI clinical tutor, who was selected to pitch at the…
![]()
The Irish Times - Miniature implantable pump treats advanced stage heart failure
Pumpinheart technology developed may improve outlook and treatment options for patients.
![]()
Irish Independent news: Irish scientists develop artificial silicone heart - Breakthrough hailed as ‘key step forward’
New heart model to help treat patients with heart failure.
![]()
Pumpinheart wins TERMIS-AM 2022 Business Plan Competition
TERG-CarDevT lab spinout startup, Pumpinheart, was awarded the TERMIS-AM Annual Conference and Exhibition Business Plan Competition on 12…
